SciBase Holding AB (publ) (SCIB.ST)
SEK 0.37
(-6.03%)
SEK 0.37
(-6.03%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 64.33 Million SEK | 29.04% |
| 2022 | 49.85 Million SEK | -41.66% |
| 2021 | 85.45 Million SEK | 44.23% |
| 2020 | 59.25 Million SEK | 28.36% |
| 2019 | 46.16 Million SEK | -43.09% |
| 2018 | 81.11 Million SEK | -36.59% |
| 2017 | 127.91 Million SEK | 25.27% |
| 2016 | 102.1 Million SEK | -33.37% |
| 2015 | 153.25 Million SEK | 268.29% |
| 2014 | 41.61 Million SEK | -4.73% |
| 2013 | 43.67 Million SEK | 82.97% |
| 2012 | 23.87 Million SEK | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 73.7 Million SEK | 45.71% |
| 2024 Q1 | 50.58 Million SEK | -21.37% |
| 2023 Q4 | 64.33 Million SEK | -22.93% |
| 2023 Q1 | 110.24 Million SEK | 121.13% |
| 2023 Q3 | 83.47 Million SEK | -15.05% |
| 2023 FY | 64.33 Million SEK | 29.04% |
| 2023 Q2 | 98.26 Million SEK | -10.86% |
| 2022 Q1 | 76 Million SEK | -11.06% |
| 2022 Q3 | 53.43 Million SEK | -17.06% |
| 2022 FY | 49.85 Million SEK | -41.66% |
| 2022 Q4 | 49.85 Million SEK | -6.69% |
| 2022 Q2 | 64.41 Million SEK | -15.25% |
| 2021 Q2 | 107.58 Million SEK | 122.9% |
| 2021 Q4 | 85.45 Million SEK | -12.61% |
| 2021 Q3 | 97.78 Million SEK | -9.11% |
| 2021 Q1 | 48.26 Million SEK | -18.54% |
| 2021 FY | 85.45 Million SEK | 44.23% |
| 2020 Q3 | 38.89 Million SEK | -19.42% |
| 2020 Q4 | 59.25 Million SEK | 52.33% |
| 2020 Q1 | 35.95 Million SEK | -22.12% |
| 2020 FY | 59.25 Million SEK | 28.36% |
| 2020 Q2 | 48.26 Million SEK | 34.26% |
| 2019 Q2 | 69.19 Million SEK | -12.92% |
| 2019 FY | 46.16 Million SEK | -43.09% |
| 2019 Q4 | 46.16 Million SEK | -19.37% |
| 2019 Q3 | 57.24 Million SEK | -17.26% |
| 2019 Q1 | 79.46 Million SEK | -2.04% |
| 2018 FY | 81.11 Million SEK | -36.59% |
| 2018 Q1 | 115.3 Million SEK | -9.86% |
| 2018 Q2 | 104 Million SEK | -9.8% |
| 2018 Q3 | 92.54 Million SEK | -11.03% |
| 2018 Q4 | 81.11 Million SEK | -12.35% |
| 2017 Q4 | 127.91 Million SEK | 83.54% |
| 2017 FY | 127.91 Million SEK | 25.27% |
| 2017 Q3 | 69.69 Million SEK | -12.46% |
| 2017 Q2 | 79.6 Million SEK | -10.94% |
| 2017 Q1 | 89.38 Million SEK | -12.46% |
| 2016 Q1 | 142.06 Million SEK | -7.3% |
| 2016 Q3 | 117.56 Million SEK | -9.0% |
| 2016 Q2 | 129.18 Million SEK | -9.06% |
| 2016 Q4 | 102.1 Million SEK | -13.15% |
| 2016 FY | 102.1 Million SEK | -33.37% |
| 2015 FY | 153.25 Million SEK | 268.29% |
| 2015 Q2 | 182.48 Million SEK | 467.29% |
| 2015 Q3 | 166.58 Million SEK | -8.71% |
| 2015 Q4 | 153.25 Million SEK | -8.01% |
| 2015 Q1 | 32.16 Million SEK | -22.7% |
| 2014 FY | 41.61 Million SEK | -4.73% |
| 2014 Q4 | 41.61 Million SEK | 0.0% |
| 2014 Q1 | - SEK | 0.0% |
| 2013 FY | 43.67 Million SEK | 82.97% |
| 2012 FY | 23.87 Million SEK | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acarix AB (publ) | 62.88 Million SEK | -2.306% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 98.043% |
| ADDvise Group AB (publ) | 3.28 Billion SEK | 98.043% |
| Arcoma AB | 81.96 Million SEK | 21.508% |
| Bactiguard Holding AB (publ) | 682.87 Million SEK | 90.579% |
| BICO Group AB (publ) | 10.19 Billion SEK | 99.369% |
| Boule Diagnostics AB (publ) | 755.1 Million SEK | 91.48% |
| CellaVision AB (publ) | 928.71 Million SEK | 93.073% |
| Clinical Laserthermia Systems AB (publ) | 57.72 Million SEK | -11.449% |
| Chordate Medical Holding AB (publ) | 21.95 Million SEK | -193.02% |
| C-Rad AB (publ) | 404 Million SEK | 84.076% |
| Duearity AB (publ) | 15.14 Million SEK | -324.815% |
| Dignitana AB (publ) | 44.83 Million SEK | -43.503% |
| Episurf Medical AB (publ) | 104.3 Million SEK | 38.318% |
| Getinge AB (publ) | 55.09 Billion SEK | 99.883% |
| Scandinavian Real Heart AB (Publ) | 102.63 Million SEK | 37.32% |
| Iconovo AB (publ) | 128.07 Million SEK | 49.77% |
| Integrum AB (publ) | 164.85 Million SEK | 60.976% |
| Luxbright AB (publ) | 40.68 Million SEK | -58.121% |
| Mentice AB (publ) | 322.52 Million SEK | 80.053% |
| OssDsign AB (publ) | 356.38 Million SEK | 81.948% |
| Paxman AB (publ) | 167.12 Million SEK | 61.505% |
| Promimic AB (publ) | 92.87 Million SEK | 30.731% |
| Qlife Holding AB (publ) | 39.04 Million SEK | -64.765% |
| ScandiDos AB (publ) | 81.47 Million SEK | 21.036% |
| Sectra AB (publ) | 3.21 Billion SEK | 97.996% |
| Sedana Medical AB (publ) | 1.01 Billion SEK | 93.656% |
| Senzime AB (publ) | 433.54 Million SEK | 85.161% |
| SpectraCure AB (publ) | 144.83 Million SEK | 55.581% |
| Stille AB | 804.89 Million SEK | 92.007% |
| Vitrolife AB (publ) | 16.39 Billion SEK | 99.608% |
| Xvivo Perfusion AB (publ) | 2.19 Billion SEK | 97.07% |